Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Turn Therapeutics Inc. (TTRX)

NASDAQ

$13,47

$-0,19

(-1,41%)

Pre-Market

Turn Therapeutics Inc. (TTRX) Live Price Chart

Last updated: ⁦2026-09-16 10:31:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Turn Therapeutics Inc. (TTRX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $13,47, with a market capitalisation of $408,45M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2,57 to $26,50. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$408,45M
Open	$13,37
Day's High	$26,50
Day's Low	$2,57
Previous Close	$13,45
Volume	82,70K
Average Volume	90,16K
P/E Ratio	--
52-Week High	$26,50
52-Week Low	$2,57
Dividend Yield	--
Earnings Date	--

Turn Therapeutics Inc. (TTRX) Pre-Market Stock Price

Turn Therapeutics Inc. (TTRX) is trading at $13,45 in pre-market trading as of 2026-09-15 23:31:00, unchanged from the previous close of $13,45

Pre-market trading shows how investors are pricing TTRX before the regular session opens. The current pre-market price is near the previous close, indicating neutral early trading sentiment.

Turn Therapeutics Inc. (TTRX) 7-Day Stock Price Change

Over the past seven days, Turn Therapeutics Inc. (TTRX) moved from $9,80 to $13,47, representing a gain of 37,46% ($3,67).

The stock traded between $9,70 and $14,39 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 163,89 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

TTRX 52-Week Price Position

Position in Range: 45,6%

52W Low$2,57

52W High$26,50

TTRX is currently trading at $13,47, placing it 45,6% of the way from its 52-week low of $2,57 to its 52-week high of $26,50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Turn Therapeutics Inc. (TTRX)?

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Turn Therapeutics Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	2
Exchange	NASDAQ
Company Website	https://www.turntherapeutics.com

How to Buy Turn Therapeutics Inc. (TTRX) Stock on MEXC

Eligible investors can buy real shares of Turn Therapeutics Inc. (TTRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for TTRX and Place Your Order

Open the RealStocks trading page and search for TTRX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Turn Therapeutics Inc. (TTRX) stock price today?

Turn Therapeutics Inc. (TTRX) is currently trading at $ 13,47, up 0,16% ($0,02) from the previous close of $ 13,45. Intraday prices update in real time during regular trading hours.

2.Is TTRX stock going up or down today?

As of 2026-09-15 23:31:00, TTRX is trading at $ 13,47, up 0,16% ($0,02) from its previous close of $ 13,45. The stock has traded between $ 2,57 and $ 26,50 during today’s regular session. Past price movements do not guarantee future results.

3.What is TTRX pre-market price?

As of 2026-09-15 23:31:00, TTRX is trading at $ 13,45 in pre-market trading, unchanged from the previous close of $ 13,45. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is TTRX after-hours price?

As of 2026-09-15 23:31:00, TTRX is trading at $ 13,64 in after-hours trading, up 1,38% ($0,19) from the regular-session close of $ 13,45. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is TTRX stock trading now?

TTRX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does TTRX sit relative to its 52-week high and low?

Over the past 52 weeks, TTRX has traded between a low of $ 2,57 and a high of $ 26,50. At $ 13,47, the stock is positioned 45,6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Turn Therapeutics Inc. in?

Turn Therapeutics Inc. (TTRX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Turn Therapeutics Inc.'s market capitalisation and where is it listed?

Turn Therapeutics Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 408,45M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is TTRX valued in terms of P/E ratio and EPS?

TTRX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0,28. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Turn Therapeutics Inc. pay a dividend?

Turn Therapeutics Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.